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Abstract 
Background 
Lymphadenopathy is a common clinical presentation of disease in South Africa (SA), 
particularly in the era of Human Immunodeficiency Virus (HIV) and tuberculosis (TB) co-
infection.  
Methods 
Data from 560 lymph node biopsy reports of specimens from patients older than 12 
years at Chris Hani Baragwanath Academic Hospital (CHBAH) between 1 January 2010 
and 31 December 2012 was extracted from the National Health Laboratory Service 
(NHLS), division of Anatomical Pathology.  Cytology reports of lymph node fine needle 
aspirates (FNAs) performed prior to lymph node biopsy in 203 patients were also 
extracted from the NHLS.  Consent was not obtained from participants for their records 
to be used as patient information was anonymized and de-identified prior to analysis. 
Results 
The majority of patients were female (55%) and of the African/black racial group (90%).  
The median age of patients was 40 years (range12-94).  The most common indication 
for biopsy was an uncertain diagnosis (more than two differential diagnoses entertained), 
followed by a suspicion for lymphoma, carcinoma and TB.  Overall, malignancy 
constituted the largest biopsy pathology group (39%), with 36% of this group being 
carcinoma and 27% non-Hodgkin lymphoma.  22% of the total sampled nodes displayed 
necrotizing granulomatous inflammation (including histopathology and cytology 
demonstrating definite, and suspicious for mycobacterial infection), 8% comprised HIV 
reactive nodes; in the remainder no specific pathology was identified (nonspecific 
reactive lymphoid hyperplasia).  Kaposi sarcoma (KS) accounted for 3% of lymph node 
pathology in this sample.  Concomitant lymph node pathology was diagnosed in four 
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cases of nodal KS (29% of the subset).  The co-existing pathologies were TB and 
Castleman disease.  HIV-positive patients constituted 49% of this study sample and the 
majority (64%) of this subset had CD4 counts less than 350 cells/ul.  27% were HIV-
negative and in the remaining nodes, the HIV status of patients was unknown.  The most 
common lymph node pathologies in HIV-positive patients were Mycobacterial infection 
(31%), HIV reactive nodes (15%), non-Hodgkin lymphoma (15%) and nonspecific 
reactive lymphoid hyperplasia (15%).  Only 9% were of Hodgkin lymphoma.  In contrast, 
the most common lymph node pathologies in HIV-negative patients were nonspecific 
reactive lymphoid hyperplasia (45%), carcinoma (25%) and Mycobacterial infection 
(11%).  In this group, non-Hodgkin lymphoma and Hodgkin lymphoma constituted 9% 
and 8%, respectively.  There were more cases of high-grade non-Hodgkin lymphoma in 
the HIV-positive group compared to the HIV-negative group.  FNA and lymph node 
biopsy had excellent agreement with regard to Hodgkin lymphoma (K 0.774, SE 0.07, 
95% CI 0.606-0.882, p=0.001), and good agreement with regard to non-Hodgkin 
lymphoma (K 0.640, SE 0.07, 95% CI 0.472-0.807, p=0.001), carcinoma (K 0.723, SE 
0.069, 95% CI 0.528-0.918, p=0.001), and mycobacterial infection (K 0.726, SE 0.07, 
95% CI 0.618-0.833, p=0.001). 
Conclusions 
The most common lymph node pathologies in CHBAH are malignancies, nonspecific 
reactive lymphoid hyperplasia, necrotizing granulomatous inflammation and HIV reactive 
nodes.  The distribution of disease differed in HIV-positive patients.  Overall, adequate 
FNA samples of lymph nodes have been found to have good correlation with lymph 
node biopsy findings in our setting. 
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